January 23, 2025) - Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) securities between November 2, 2023 and October 30, 2024, ...
The new Enron has been dismissed by many as a joke or a publicity stunt, but recent filings and a newly-revealed executive ...
The exposé led to the company’s CEO going to jail and to Anderson’s short-selling firm, Hindenburg Research, becoming one of ...
CASE ALLEGATIONS: BioAge Labs is a clinical-stage biopharmaceutical company that develops therapeutic product candidates for metabolic diseases. In the IPO, BioAge Labs sold 12.65 million shares at ...
Responsible private sector leadership, with a true connection between business success and societal stability, is the best ...
With a climate change denier as US president, Joe Murphy and Joe Robertson’s politics-as-glossy-spectacle could not be more ...
President Trump on Monday granted pardons to about 1,500 Jan. 6 defendants, making good on his campaign promise to end the ...
Rumors have been floating around about a revolutionary egg-shaped nuclear reactor that can power a home for up to 10 years – based in Fresno. According to Enron, ...
Something is stirring beneath the surface of a revived Enron, and it seems to be pushing a parody product of a stylish ...
For the last half-decade or so, the last thing any CEO wanted to was to see their company’s name in print alongside ...
Enron, or the satire-infused Frankenstein version of the long-deceased company, filed an application Tuesday to become Texas’ ...
Chris Hughes is a Bloomberg Opinion columnist covering deals. Previously, he worked for Reuters Breakingviews, the Financial ...